Suscribirse

THE DIAGNOSIS AND MANAGEMENT OF ASTHMA DURING PREGNANCY - 04/09/11

Doi : 10.1016/S0889-8561(05)70181-8 
Allan T. Luskin, MD a, Myron A. Lipkowitz, MD, RPh b
a Department of Medicine, University of Wisconsin, Madison; Respiratory Center, Dean Medical Center, Sun Prairie, Wisconsin (ATL) 
b Deceased; formerly from the Department of Family Practice, Kimball Medical Center, St. Barnabas Health Care System, Lakewood, New Jersey 

Resumen

Asthma is one of the most common illnesses that complicate pregnancy. It has been conservatively estimated that 1% to 4% of pregnancies are affected by bronchial asthma, but this figure may be much higher, as 10% or more of the general population appear to have nonspecific airway hyperreactivity, a hallmark of asthma.23, 35 If left untreated, asthma can lead to serious complications for both mother and fetus. Fortunately, when appropriately managed, mother and baby should have an outcome not significantly different from pregnancies unaffected by asthma.2, 11, 24, 55 Following the tragic experiences with thalidomide during the 1960s,56 many women are reluctant to take, and some physicians to prescribe, medications during pregnancy. Although this reluctance to take medication can be very problematic, it may provide an opportunity to place emphasis on preventive measures, including smoking cessation and the avoidance of environmental triggers; however, medications will be necessary in many cases.

Because extensive controlled human safety data on the effects of exposure to most medications during pregnancy is lacking, it is generally recommended that the physician prescribe agents whose long track records have failed to demonstrate teratogenic or other adverse maternal or fetal effects. Prescribing any medication during pregnancy entails evaluating expected benefits and determining that these benefits outweigh the risks of adverse effects. When giving any treatment during pregnancy, one must obtain adequate informed consent, including an explanation of the consequences of failing to prescribe therapy that may alleviate the effects of potentially life-threatening asthma to mother, fetus, or both.20

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Allan T. Luskin, MD, Dean Medical Center, 10 Tower Drive, Sun Prairie, WI 53590, e-mail: ssluskin@msn.com


© 2000  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 20 - N° 4

P. 745-761 - novembre 2000 Regresar al número
Artículo precedente Artículo precedente
  • THE EFFECT OF PREGNANCY ON THE COURSE OF ASTHMA
  • Joan C. Gluck, Paul A. Gluck
| Artículo siguiente Artículo siguiente
  • THE MANAGEMENT OF SEVERE ASTHMA DURING PREGNANCY
  • Paul A. Greenberger

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.